Abattis Bioceuticals Market Risk Adjusted Performance

ATTBF Stock  USD 0.0001  0.00  0.00%   
Abattis Bioceuticals market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Abattis Bioceuticals Corp or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
Abattis Bioceuticals Corp has current Market Risk Adjusted Performance of 0.

MRAP

 = 

ER[a] + (1/BETA - 1)

X

ER[a] - RFR)

 = 
0
ER[a] = Expected return on investing in Abattis Bioceuticals
RFR = Risk Free Rate of return. Typically T-Bill Rate
BETA = Beta of the asset with market or selected benchmark.

Abattis Bioceuticals Market Risk Adjusted Performance Peers Comparison

Abattis Market Risk Adjusted Performance Relative To Other Indicators

Abattis Bioceuticals Corp is rated below average in market risk adjusted performance category among its peers. It is currently under evaluation in maximum drawdown category among its peers .
Compare Abattis Bioceuticals to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas